Fitbit has earned regulatory clearance in the U.S. and the EU for an electrocardiogram (ECG) app that detects atrial fibrillation, or AFib – an irregularity of the heartbeat that can increase the risk of a stroke. Specifically, the device has received 510(k) clearance from the U.S. Food and Drug Administration ...
Already an SGI Europe subscriber? Sign in here
By registering today you’ll get access to:
For full access to our business intelligence and to receive in-depth insights, analysis, downloadable charts, infographics and more, become a member today
For corporate membership options and enquiries, please visit our corporate membership page